These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21318422)

  • 1. Impact of an antibiotic restriction program on antibiotic utilization in the treatment of community-acquired pneumonia in a Veterans Affairs Medical Center.
    Mansouri MD; Cadle RM; Agbahiwe SO; Musher DM
    Infection; 2011 Feb; 39(1):53-8. PubMed ID: 21318422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the impact of an antimicrobial stewardship program on the length of stay of immune-competent adult patients admitted to a hospital ward with a diagnosis of community-acquired pneumonia: A quasi-experimental study.
    DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L
    Am J Infect Control; 2016 May; 44(5):e73-9. PubMed ID: 26899527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.
    Hsu JL; Siroka AM; Smith MW; Holodniy M; Meduri GU
    Int J Infect Dis; 2011 Jun; 15(6):e382-7. PubMed ID: 21393043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential for cost-savings in the care of hospitalized low-risk community-acquired pneumonia patients in China.
    Zhou QT; He B; Zhu H
    Value Health; 2009; 12(1):40-6. PubMed ID: 18637052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia.
    Foolad F; Huang AM; Nguyen CT; Colyer L; Lim M; Grieger J; Li J; Revolinski S; Mack M; Gandhi T; Wainaina JN; Eschenauer G; Patel TS; Marshall VD; Nagel J
    J Antimicrob Chemother; 2018 May; 73(5):1402-1407. PubMed ID: 29462306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Appropriate use of antibiotics in hospitals. Investigating clinical practices in management of community-acquired pneumonia].
    Navas D; Caillon J; Potel G
    Presse Med; 2005 Dec; 34(22 Pt 1):1687-95. PubMed ID: 16374388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia.
    Cortoos PJ; Gilissen C; Laekeman G; Peetermans WE; Leenaers H; Vandorpe L; Simoens S
    Scand J Infect Dis; 2013 Mar; 45(3):219-26. PubMed ID: 23113827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989.
    Coleman RW; Rodondi LC; Kaubisch S; Granzella NB; O'Hanley PD
    Am J Med; 1991 Apr; 90(4):439-44. PubMed ID: 1901446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Community-acquired pneumonia: influence of the duration of intravenous antibiotic therapy on hospital stay and the cost-benefit ratio].
    Fernández Alvarez R; Gullón Blanco JA; Rubinos Cuadrado G; Jiménez Sosa A; Hernández García C; Medina Gonzálvez A; González Martín I
    Arch Bronconeumol; 2001 Oct; 37(9):366-70. PubMed ID: 11674935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inpatient care of community-acquired pneumonia: the effect of antimicrobial guidelines on clinical outcomes and drug costs in Canadian teaching hospitals.
    Marras TK; Jamieson L; Chan CK
    Can Respir J; 2004 Mar; 11(2):131-7. PubMed ID: 15045044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of antibiotic changes on hospital stay and treatment duration in community-acquired pneumonia.
    Ryu J; Kim NH; Ohn JH; Lim Y; Lee J; Kim HW; Kim SW; Park HS; Kim ES; Yoon S; Heo E; Kim ES
    Sci Rep; 2024 Sep; 14(1):22669. PubMed ID: 39349548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study.
    Høgli JU; Garcia BH; Svendsen K; Skogen V; Småbrekke L
    BMC Pulm Med; 2020 Jun; 20(1):169. PubMed ID: 32539706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact and barriers of a pharmacist-led practice with computerized reminders on intravenous to oral antibiotic conversion for community-acquired pneumonia inpatients.
    Xu S; Wang X; Song Z; Han F; Zhang C
    J Clin Pharm Ther; 2021 Aug; 46(4):1055-1061. PubMed ID: 34101230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Hospital Practice Patterns for Antibiotic Administration for Pneumonia on Hospital Lengths of Stay and Costs.
    Christensen EW; Spaulding AB; Pomputius WF; Grapentine SP
    J Pediatric Infect Dis Soc; 2019 May; 8(2):115-121. PubMed ID: 29438527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
    Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG
    Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic de-escalation therapy in patients with community-acquired nonbacteremic pneumococcal pneumonia.
    Uda A; Tokimatsu I; Koike C; Osawa K; Shigemura K; Kimura T; Miyara T; Yano I
    Int J Clin Pharm; 2019 Dec; 41(6):1611-1617. PubMed ID: 31654366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia.
    Webb BJ; Sorensen J; Mecham I; Buckel W; Ooi L; Jephson A; Dean NC
    Chest; 2019 Nov; 156(5):843-851. PubMed ID: 31077649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical pathway for community-acquired pneumonia: an observational cohort study.
    Frei CR; Bell AM; Traugott KA; Jaso TC; Daniels KR; Mortensen EM; Restrepo MI; Oramasionwu CU; Ruiz AD; Mylchreest WR; Sikirica V; Raut MR; Fisher A; Schein JR
    BMC Infect Dis; 2011 Jul; 11():188. PubMed ID: 21733161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.